BeyondSpring (NASDAQ:BYSI) Stock Price Down 6.6%

BeyondSpring Inc. (NASDAQ:BYSI) was down 6.6% on Thursday . The stock traded as low as $2.26 and last traded at $2.27. Approximately 28,389 shares changed hands during trading, a decline of 85% from the average daily volume of 185,227 shares. The stock had previously closed at $2.43.

BeyondSpring Trading Down 6.6 %

The company has a fifty day simple moving average of $2.41 and a two-hundred day simple moving average of $1.46.

Hedge Funds Weigh In On BeyondSpring

Institutional investors have recently bought and sold shares of the stock. Decheng Capital Management III Cayman LLC bought a new position in BeyondSpring during the third quarter valued at about $3,967,000. Capstone Capital Wealth Advisors bought a new position in shares of BeyondSpring in the fourth quarter worth about $45,000. Finally, Decheng Capital LLC bought a new position in shares of BeyondSpring in the fourth quarter worth about $4,450,000. 40.29% of the stock is currently owned by institutional investors.

About BeyondSpring

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.